FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/091918 [Registered on: 28/07/2025] Trial Registered Prospectively
Last Modified On: 28/07/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia
Process of Care Changes 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A study comparing two ways to monitor anasthesia to see which helps patients wake up faster from anasthesia in patients undergoing elective breast surgeries in a tertiary cancer care hospital 
Scientific Title of Study   A prospective randomized comparative study of recovery time by using bispectral index versus end tidal agent concentrate monitoring in patients undergoing elective breast surgeries in a tertiary cancer care hospital 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR BABY LALMALSAWMI 
Designation  POST GRADUATE RESIDENT 
Affiliation  KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY 
Address  ROOM 101, FIRST FLOOR, SHANTHIDHAMA BLOCK,KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY, BANGALORE, 560029
ROOM 105, Ground Floor, OT complex,KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY, BANGALORE, 560029
Bangalore
KARNATAKA
560029
India 
Phone  9612615935  
Fax    
Email  babylalmalsawmi@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR HENJARAPPA K S 
Designation  ASSOCIATE PROFESSOR 
Affiliation  KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY 
Address  KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY, OT COMPLEX, FIRSTV FLOOR,ROOM 105, DR MH MARIGOWDA ROAD BANGALORE 560029

Bangalore
KARNATAKA
560029
India 
Phone  9448933654  
Fax    
Email  drhenjarappa@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR BABY LALMALSAWMI 
Designation  POSTGRADUATE RESIDENT 
Affiliation  KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY, BANGALORE 
Address  KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY, ROOM 101, FIRST FLOOR, SHANTHIDHAMA BLOCK, BANGALORE, 560029

Bangalore
KARNATAKA
560029
India 
Phone  9612615935  
Fax    
Email  babylalmalsawmi@gmail.com  
 
Source of Monetary or Material Support  
KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY, BANGALORE 
 
Primary Sponsor  
Name  DR BABY LALMALSAWMI 
Address  KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY, ROOM 101, FIRST FLOOR SHANTHIDHAMA BLOCK,BANGALORE 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR BABY LALMALSAWMI  KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY, BANGALORE  DEPARTMENT OF ANAESTHESIOLOGY AND PAIN RELIEF FIRST FLOOR, OT COMPLEX
Bangalore
KARNATAKA 
9612615935

babylalmalsawmi@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
MEDICAL ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C509||Malignant neoplasm of breast of unspecified site, (2) ICD-10 Condition: C501||Malignant neoplasm of central portion of breast, (3) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  ANAESTHETIC AGENT DESFLURANE  NIL 
Comparator Agent  BISPECTRAL INDEX VERSUS END TIDAL ANAESTHETIC AGENT  NA 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  90.00 Year(s)
Gender  Both 
Details  1. Patients undergoing elective breast surgery
2. Patients aged more than 18 years
3. American Society of Anaesthesiology (ASA) physical status 1 and 2
4. Provised consent to procedure  
 
ExclusionCriteria 
Details  1. Patients with history of long term used of anti-convulsants, opiates, benzodiazepines, cocaine, alcohol
2. Patients with pre-existing renal, hepatic, cardiac disease and dementia 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To assess extubation time and recovery time using bispectral index and end tidal anaesthetic agent  2-3hours 
 
Secondary Outcome  
Outcome  TimePoints 
total consumption of desflurane, hemodynamic stability of the patients and discharge from post-anaesthetic care unit  1-2hours 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   16/09/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This a randomized comparative study on recovery time from post operative procedure using two monitoring device bispectral index and end tidal anaesthetic agent. this two device have been proven to be effective for this purpose it also assess the anaesthetic depth of the patients as well. Group A will be the bispectral group where the value will be kept between 40-60 and Group B will be the end tidal anaesthetic agent group where the minimum  alveolar concentratiuon (MAC) will be kept at 1. After shifting the patients to operation room, the will be connect to standard american socitey of anaesthsiology monitor like like heart rate, oxygen saturation , bloopd pressure,electrocardiogramand will recorded at baseline, at 5minustes, at 30 minustes, at 60 minutrs, at 120 minutes. For anaesthetic agent desflurane will be used and will be titrated according to the bispectral index value and end tidal agent value (MAC) and will be switch off an the last stitch of skin incision.the time taken for the patient to be extubated and recover from sugery will be recorded in both the group . 
Close